NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable.
Executive Appointments and Promotions
Dr. Sean Fenton
Lloyd Hilton Taewon Kim Paul Korathu Michelle LaBonte Marcia Leishman Carter McBride Dr. Eran Nadav Bud Powell Kenny Rankin Peter Rossmann Kelly Stiltner Russell Upchurch Marinda Williams Eisai Hires and Promotes Eisai, Teaneck, N.J., the U.S. subsidiary of Tokyo-based Eisai Co., a research-based human healthcare company, has made several changes to its staff. Manoj Aggarwal has been promoted to senior district manager, Baltimore district, primary-care salesforce, from the previous role of district manager. James Bongi has been hired as project portfolio manager, sales and marketing. Jeffrey Chodos has been promoted to senior district manager, Ventura district, primary-care salesforce. He was previously district manager. Colette Curran has been hired as manager, market research. Brian Doyle has been hired as senior product manager, critical care/oncology marketing. Sean Fenton, D.O., has been hired as associate medical director. Patrick Grenyo has been promoted to senior district manager, Billings district, primary-care salesforce, from his previous post as district manager. Lloyd Hilton has been hired as district manager, Cleveland district, specialty salesforce. Taewon Kim has been hired as product manager, critical-care/oncology marketing. Paul Korathu has been promoted to senior manager, business development, from manager, business development. Michelle LaBonte has been hired as associate director, customer development. Marcia Leishman has been hired as senior product manager. Carter McBride has been hired as senior district manager, Oklahoma City district, specialty salesforce. Eran Nadav, Ph.D., has been promoted to director, business development. He previously was associate director, scientific evaluation. In this new role, he assumes additional responsibilities for identifying and executing strategic business deals for Eisai. He has a Ph.D. in biochemistry from the lab of Nobel Laureate Professor Aaron Ciechanover and an MBA from Tel Aviv University. Bud Powell has been promoted to senior district manager, New Orleans district, primary-care salesforce. He was previously district manager. Kenny Rankin has been hired as regional sales director, central region, specialty salesforce. Before joining Eisai, Mr. Rankin spent eight years at Sepracor Pharmaceuticals, most recently as a regional sales director. He has a bachelor’s degree in communications from Bowling Green State University. Peter Rossmann has been promoted to senior district manager, Little Rock district, primary-care salesforce. Mr. Rossmann most recently was district manager. Kelly Stiltner has been promoted to district manager, Cincinnati district, from medical sales specialist. Russell Upchurch has been promoted to senior manager, quality control, from manager, quality control. Marinda Williams has been promoted to senior district manager, Knoxville district, specialty salesforce, from her previous position as district manager. John M. Carroll Dr. Thomas P. Koestler Dr. Catherine D. Strader Schering-Plough Makes Executive Changes Schering-Plough, a global, science-based healthcare company in Kenilworth, N.J., has appointed John M. Carroll as VP, global internal audits. Previously, Mr. Carroll was with American Standard, where he served as VP, general auditor, and an elected officer. He is a certified public accountant with a B.S. in accounting from St. John’s University. Thomas P. Koestler, Ph.D., has been named executive VP and president of Schering-Plough Research Institute (SPRI), the research and development arm of Schering-Plough. Dr. Koestler is responsible for all aspects of SPRI, including heading up the Pharmaceutical Leadership Board (PLB). Dr. Koestler, who originally joined Schering-Plough in 2003, most recently was executive VP, global development, SPRI. Before joining Schering-Plough, he was senior VP and head of global regulatory affairs for Pharmacia. He has a Ph.D. from the State University of New York (SUNY) at Buffalo, Roswell Park Memorial Institute, where he studied medicine and pathology. He has a B.S. in biology from Daeman College. Additionally, Catherine D. Strader, Ph.D., has been promoted to executive VP, SPRI, and chief scientific officer. She is responsible for the drug-discovery operations of Schering-Plough, and she chairs the Research Leadership Committee, with responsibility for the company’s preclinical research portfolio. Dr. Strader previously was executive VP, discovery research, SPRI. Before joining Schering-Plough in 1995, she was executive director for the department of molecular pharmacology and biochemistry at Merck Research Laboratories. She has a B.S. in chemistry from the University of Virginia and a Ph.D. in chemistry from the California Institute of Technology. She completed postdoctoral work at the Howard Hughes Medical Institute at Duke University. Tim Ravenscroft Bristol-Myers Squibb Medical Imaging Names President Tim Ravenscroft has been appointed president of Bristol-Myers Squibb Medical Imaging, North Billerica, Mass., the cardiovascular imaging subsidiary of Bristol-Myers Squibb. Mr. Ravenscroft has more than 28 years of experience in the healthcare industry. Most recently, he served as VP of Bristol-Myers Squibb’s global virology franchise. He has a master’s degree from City University and a bachelor’s degree in microbiology and biochemistry from East London University. Biotech POOL Michael P. Bailey ImClone Promotes Senior VP ImClone Systems has promoted Michael P. Bailey to senior VP, commercial operations, with principal responsibility for the company’s efforts to market and sell Erbitux. New York-based ImClone develops and commercializes targeted biologic treatments to address a variety of cancers. Mr. Bailey joined ImClone in 1999 and most recently served as VP of marketing since 2003. Before joining the company, he was a group product manager at Genentech. He earned his B.S., with honors, from Saint Lawrence University and his MBA, with honors, from the University of Notre Dame Graduate School of Business. Dr. Elmar R. Burchardt George W. Dunbar jr. Aastrom Fills Key Management Positions Elmar R. Burchardt, M.D., Ph.D., has joined Aastrom Biosciences as senior director medical affairs. Aastrom, Ann Arbor, Mich., develops products for the repair or regeneration of multiple human tissues, based on a proprietary tissue repair cell (TRC) adult stem-cell technology. Dr. Burchardt directs all ongoing and planned clinical programs and leads the development of new indication programs. He most recently was medical director for Miltenyi Biotec. He earned his M.Sc. and Ph.D. degrees in biochemistry, along with his M.D., from Hannover Medical School. Additionally, George W. Dunbar Jr., has joined Aastrom as CEO, president, and a member of the company’s board of directors. Mr. Dunbar previously spent 15 years as the chief executive for established and early stage healthcare companies, including Quantum Dot, Targesome, Epic Therapeutics, Metra Biosystems, and StemCells. He earned his B.S. and MBA degrees from Auburn University. Dr. Sidney Mazel MedImmune Creates Strategic Planning Post Sidney Mazel, Ph.D., has joined MedImmune’s management team as senior VP, product planning and portfolio management. MedImmune, Gaithersburg, Md., is a biotechnology company focused on the areas of infectious disease, cancer, and inflammatory diseases. Dr. Mazel is responsible for new product planning, project management, market research, and competitive intelligence. Dr. Mazel previously held a number of senior leadership positions at Merck, most recently serving as VP of worldwide marketing planning for the company’s obesity and atherosclerosis franchise. He earned his bachelor’s and master’s degrees from George Washington University and his Ph.D. from the University of Maryland. Dr. Cecil B. Pickett Biogen Idec Names R&D President Cecil B. Pickett, Ph.D., has joined Biogen Idec as president of research and development. He also has joined the company’s board of directors. Biogen Idec, Cambridge, Mass., develops, manufactures, and commercializes novel therapies in oncology, neurology, and immunology. Dr. Pickett spent 13 years at Schering-Plough in several senior R&D positions, most recently as corporate senior VP and president of Schering-Plough Research Institute. He has a Ph.D. in cell biology from the University of California, Los Angeles, and his B.Sc. in biology from California State University at Hayward. Dr. Michael Tansey La Jolla Pharmaceutical Appoints Chief Medical Officer Michael Tansey, M.D., has been named as chief medical officer at La Jolla Pharmaceutical, a San Diego-based biotech company developing therapeutics for antibody-mediated autoimmune diseases and inflammation. Dr. Tansey has 25 years of experience and previously was chief medical officer and senior VP at Pharmacia. He earned a medical degree from Manchester University and a doctorate in experimental and clinical studies, with a focus on the metabolic aspects of myocardial infarction, from the University of Cape Town. Biopharmaceutical POOL Dr. Richard Chin Dr. Peter A. Harris Oxigene Makes Leadership Appointments Oxigene, Waltham, Mass., a developer of biopharmaceutical compounds designed to treat cancer and certain ophthalmologic diseases, has hired Richard Chin, M.D., as president and CEO. Dr. Chin, a board-certified internist, most recently was senior VP and head of global development for Elan. He earned his medical degree from Harvard Medical School and a B.A. in biology, magna cum laude, from Harvard University. In addition, he holds master’s and bachelor of arts degrees in law, with honors, from Oxford University under a Rhodes Scholarship. Oxigene also has appointed Dr. Peter A. Harris to the newly created role of chief medical officer. He most recently served as a development director for Kudos Pharmaceuticals. Dr. Harris earned his bachelor of science degree, with honors, from the University of London and his bachelor of medicine/bachelor of surgery degree (the U.S. equivalent of an M.D.) from the Royal London Hospital Medical School at the University of London. He also holds a diploma in pharmaceutical medicine from the Royal College of Physicians. Dr. James L. Freddo Anadys Names Chief Medical Officer James L. Freddo, M.D., has joined Anadys Pharmaceuticals as chief medical officer. Anadys Pharmaceuticals is a San Diego-based biopharmaceutical company discovering, developing, and commercializing novel small-molecule medicines for hepatitis, other serious infections, and cancer. In this new role, Dr. Freddo leads clinical operations for the company’s clinical programs and serves on the Anadys-Novartis joint steering committee. He was most recently VP, clinical site head and development site head, at Pfizer Global Research and Development. He holds a B.S. in medical technology from the State University of New York at Stony Brook and an M.D. from the University of North Carolina, where he also completed his fellowship training. Dr. J. Michael Hamilton Avalon Appoints Chief Medical Officer J. Michael Hamilton, M.D., has joined Avalon Pharmaceuticals in the newly created position of chief medical officer. Avalon, Germantown, Md., is a biopharmaceutical company focused on the discovery and development of small-molecule therapeutics. Dr. Hamilton develops clinical strategies and priorities and also oversees the implementation of Phase I-III clinical trials. Dr. Hamilton has 20 years of expertise in the field of oncology, and he most recently served as group director of oncology, MDC, for GlaxoSmithKline. He earned his bachelor’s degree from the University of Connecticut and his M.D. from the George Washington University. Scott T. Megaffin Adolor Names Marketing VP Scott T. Megaffin has been named VP of marketing at Adolor, Exton, Pa., a biopharmaceutical company specializing in pain-management products. A 20-year industry veteran, Mr. Megaffin is responsible for the development of the strategic marketing efforts for the company’s product candidates. He most recently was a senior director of marketing at Schering-Plough. Dr. George H. Talbot Cerexa Appoints Chief Medical Officer George H. Talbot, M.D., has been named chief medical officer and executive VP of Cerexa, a biopharmaceutical company that discovers, develops, and commercializes novel therapies to treat serious, antibiotic-resistant infections. Dr. Talbot manages all of the company’s R&D efforts. Before joining Cerexa, Dr. Talbot held various positions in the anti-infectives division of Aventis Pharmaceuticals and its predecessor company, Rhone-Poulenc Rorer. A graduate of the Yale University School of Medicine, Dr. Talbot completed his training in internal medicine and infectious diseases in the University of Pennsylvania hospital system. Dr. Charles P. Theuer Tracon Names President and CEO Tracon Pharmaceuticals, a San Diego-based biopharmaceutical company developing next-generation targeted therapies for cancer, has appointed Charles P. Theuer, M.D., Ph.D., as president and CEO. Dr. Theuer joins Tracon from TargeGen, where he was chief medical officer. He holds a B.S. from the Massachusetts Institute of Technology, an M.D. from the University of California at San Francisco, and a Ph.D. from the University of California at Irvine. Specialty POOL Armando Anido Auxilium names CEO and President Armando Anido has been named CEO, president, and director of Auxilium Pharmaceuticals, Malvern, Pa., a specialty pharmaceutical company focused on developing and marketing products for urology, sexual health, and other indications. Mr. Anido previously served as executive VP of sales and marketing at MedImmune. He has a B.S. in pharmacy and an MBA from West Virginia University. Dr. Brian M. Gallagher Magen Names President and CEO Magen BioSciences, Cambridge, Mass., a specialty pharmaceutical company developing proprietary therapies for the dermatology market, has named Brian M. Gallagher, Ph.D., as president and CEO. Dr. Gallagher comes to Magen from CollaGenex Pharmaceuticals, where he was chairman and CEO. He previously held several executive positions at Bristol-Myers Squibb. Jennifer L. Good Penwest Names CEO Penwest Pharmaceuticals has named Jennifer L. Good as its CEO and a member of the board of directors. Penwest, Danbury, Conn., develops pharmaceutical products, focused principally on nervous system disorders, based on proprietary drug-delivery technologies. Ms. Good joined the company as chief financial officer when it was formed in 1997. She most recently served as president and chief operating officer. Emerging POOL Dr. W. James Alexander BioCryst Names Chief Medical Officer W. James Alexander, M.D., has joined BioCryst Pharmaceuticals as senior VP, clinical and regulatory operations, and chief medical officer. BioCryst, Birmingham, Ala., uses crystallography and structure-based drug design to develop novel small molecules to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections. Most recently, Dr. Alexander was senior VP, product development, and chief medical officer at Pozen. Dr. Alexander earned his medical degree from the University of Mississippi. He is board certified in internal medicine and infectious diseases. Additionally, he has a master’s in public health from the University of Alabama at Birmingham. Aileen Ryan Vion Expands Senior Management Aileen Ryan has joined Vion Pharmaceuticals’ senior-management team as VP, regulatory affairs. Vion Pharmaceuticals, New Haven, Conn., develops and commercializes innovative cancer therapeutics. Ms. Ryan oversees the global regulatory strategy for the company. She was previously the head of global regulatory strategy, oncology, at Bayer Pharmaceuticals. Dr. Katherine J. Turner Nucryst Names VP of Research Nucryst Pharmaceuticals, Wakefield, Mass., has appointed Katherine J. Turner, Ph.D., as VP of research. Nucryst develops, manufactures, and commercializes medical products that fight infection and inflammation. Most recently, Dr. Turner was VP, validation biology, at Biogen Idec. Dr. Turner earned her B.Sc., with honors, at the University of Sussex and her M.S. and Ph.D. degrees in biochemistry at Virginia Tech. In addition, she conducted postdoctoral research at Brandeis University and London University. Agency POOL Mary Barnes Reena Buddhdev Dave Cap Kisha Jones Angela Miller Doug Mills Bret Rose Brooke Sellars GSW Adds Staff GSW Worldwide, Westerville, Ohio, an inVentiv Health company and one of the largest healthcare advertising agencies, has added several new staff members. Mary Barnes has been named account executive, responsible for managing daily activities with an account team. Previously, Ms. Barnes served as account executive at Third Element Interactive. She has a bachelor’s degree from The Ohio State University (OSU). Reena Buddhdev has been named senior account executive, responsible for day-to-day management for one of the agency’s pharmaceutical accounts. Most recently, she was account executive at Barefoot Advertising. She has a bachelor’s degree from Vanderbilt University. Dave Cap has been appointed senior brand designer, responsible for leading, developing, and connecting advertising design to client concepts. Most recently, Mr. Cap served as art director for Rickabaugh Graphics. He has a bachelor’s degree from Columbus College of Art and Design. Kisha Jones has been appointed business development manager, responsible for managing the business development process for several accounts. She most recently was employed by Victoria’s Secret Stores as creative, visual, and marketing assistant. Ms. Jones has a bachelor’s degree from Norfolk State University and a master’s degree from Franklin University. Angela Miller has been appointed account director with responsibilities as an on-site client representative in Chicago. Most recently, she was group account supervisor for Hamilton Communications Group. She holds a bachelor’s degree from University of Wisconsin-Milwaukee. Doug Mills has been promoted to senior VP of client services. In this role, he leads several of GSW’s pharmaceutical accounts. Mr. Mills joined the agency in 1996 as a media manager. Since then, he has held several positions of increasing responsibility, most recently VP of client services. He has a bachelor’s degree in marketing from Miami University. Bret Rose has been named integrated designer, responsible for print, Internet, and interactive materials. Previously, he served as senior graphic designer at Kingston. He has a bachelor’s degree from OSU. Brooke Sellars has been appointed account director with responsibilities as an on-site client representative in Chicago. She previously served as group account director at Hamilton Communications Group. Ms. Sellars holds a bachelor’s degree from the University of Michigan. James Christie Alyce Erdekian Dr. Chris Gutteridge Brian Purcell Philip Simmons Centron Adds Staff Centron, a HealthSTAR Communications company, has added several new staff members to its account teams. The full-service medical communications agency is based in New York. James Christie has been named VP, account group supervisor. He spent the last five years at Saatchi & Saatchi Healthcare, Lyons Lavey Nickel Swift (LLNS), and LifeBrands. Alyce Erdekian comes to the agency as director of strategic publication planning. Previously, Ms. Erdekian was an associate editor at Adelphi. In other agency news, Chris Gutteridge, Pharm.D., has been appointed medical communications director. Dr. Gutteridge previously spent four years at Photosound as a medical communications manager. Brian Purcell has been hired as account supervisor. Before joining Centron, he spent five years at KPR in account management. Philip Simmons comes to the agency as copy supervisor. He previously was a senior copywriter at Foote Coner Belding. Meg Columbia-Walsh CommonHealth Expands Management Team Meg Columbia-Walsh has joined CommonHealth as managing partner and president, responsible for all consumer, patient, and interactive businesses. CommonHealth is a WPP Group company and a healthcare-communications network with headquarters in Parsippany, N.J. Ms. Columbia-Walsh has more than 20 years of experience in healthcare. Previously she was employed at Faith Popcorn’s BrainReserve as managing director, with a specific focus on the healthcare and technology sectors. Katy Dalton-Rigsby Stonefly Names Account Services VP Stonefly Communications Group, Westerville, Ohio, has promoted Katy Dalton-Rigsby to VP of account services. Ms. Dalton-Rigsby is responsible for leading several pharmaceutical accounts. Stonefly, an inVentiv Health company, is a customer-centric healthcare advertising agency. Ms. Dalton-Rigsby joined the agency as an account director in 2004 when it was launched. Before that, she was account director in the public relations department of GSW Worldwide, another inVentiv Health company. She has a bachelor’s degree from Marshall University and an MBA from Franklin University. John Dietz Noesis Hires New Creative Chief Noesis, CommonHealth’s professional advertising and promotion unit, based in Morristown N.J., has appointed John Dietz as executive VP, chief creative officer. Mr. Dietz has nearly 20 years of experience in advertising and pharmaceutical marketing. Most recently, he was senior VP, group creative director at DDB Rx. Chris Drew Blue Diesel Hires Technology VP Blue Diesel, an interactive marketing company and a member of the inVentiv Health group, has hired Chris Drew as VP of technology, responsible for the leadership, strategy, and direction of technology services. Mr. Drew brings to Blue Diesel, Westerville, Ohio, more than 20 years of IT experience. Most recently, he was managing director, professional services, at Affiliated Resource Group. He has a degree from the Arizona Technical Institute. Michael Durand Ogilvy PR Builds Team Michael Durand has joined Ogilvy Public Relations Worldwide as a managing director. Ogilvy PR is a global marketing communications firm with headquarters in New York. As part of the firm’s Strategy+Planning team, Mr. Durand drives growth with existing healthcare clients and participates in business development initiatives. He joins Ogilvy PR from Porter Novelli, where he was a partner, as well as founder and senior counselor in the healthcare practice. Molly Henry Jill Kaplan Anne Martin HealthEd Expands Health Education Team HealthEd, a patient-education marketing firm based in Clark, N.J., has hired Molly Henry, Jill Kaplan, and Anne Martin to its health education team. Ms. Henry has been appointed manager of health education. Previously, she was director of the Greater Illinois Chapter of the Alzheimer’s Association. She has a master’s degree in social work. Ms. Kaplan has been named director of health education. Before joining HealthEd, she worked for the Saint Barnabas Cancer Center, where she developed patient, caregiver, and community psycho-education programs. She is a licensed clinical social worker. Ms. Martin has been named coordinator for health education. Most recently, she was director of medical student and resident affairs at the California Academy of Family Physicians. A certified health education specialist, Ms. Martin has a master of public health degree and is a Certified Health Education Specialist (CHES). Linda Hutchins Cadient Appoints Group Account Director Cadient Group, West Conshohocken, Pa., a strategic interactive marketing agency serving the healthcare industry, has named Linda Hutchins group account director. Previously, she spent seven years as managing director for the Philadelphia office of EuroRSCG 4D. She has an MBA from the Widener University School of Business and a bachelor’s degree from East Carolina University. Mark Klapper Kim Levy Rick Mazzetti MicroMass Strengthen’s Strategic Services Group MicroMass Communications, Cary, N.C., has hired Mark Klapper, as VP, senior strategist. MicroMass is a patient-centric, behavior-based relationship marketing agency. Mr. Klapper has 20 years of experience and most recently was executive VP, director of planning and consulting services, at Unit 7. Kim Levy also has been named VP, senior strategist. She leads the strategic direction for several of MicroMass’ oncology accounts. Ms. Levy spent the last three years consulting. Additionally, Rick Mazzetti has been hired as VP, senior strategist, responsible for strategy development for the agency’s largest account. Mr. Mazzetti’s 20 years of pharmaceutical experience includes marketing, strategic managed-care marketing, sales management, and alliance management at companies including Quintiles Transnational, GlaxoSmithKline, and LipoScience. Megan Myers Melissa Storer David Westaway Navicor Adds Staff Megan Myers has joined the Navicor Group, Westerville, Ohio, as a copywriter, responsible for writing content for various accounts. Navicor, an inVentiv Health company, is a full-service advertising agency focused exclusively on oncology and immunology. Most recently, she was a creative writer and public-relations associate at Entific Medical Systems USA. She holds a bachelor’s degree from Otterbein College. Melissa Storer has been appointed creative services supervisor with responsibilities for project management. Before joining Navicor, Ms. Storer was production manager at Victoria’s Secret. She has a bachelor’s degree from Miami University. Navicor has appointed David Westaway as VP of account services, responsible for expanding the agency’s client base and providing strategic insight to clients. Most recently, he served as chief operating officer for Zivena. He has a bachelor’s degree in pharmacy from the University of Bradford. Helayne Spivak CCA Advertising Names Chief Creative Officer CCA Advertising, a full-service healthcare agency with headquarters in New York, has named industry veteran Helayne Spivak chief creative officer. She is responsible for building the company’s consumer-health business. Previously, Ms. Spivak was worldwide creative officer for J. Walter Thompson and chief creative officer at Young & Rubicam. Holly Wright AbelsonTaylor Names Consumer Pro for DTC Launch AbelsonTaylor, a Chicago-based pharmaceutical advertising agency, has hired Holly Wright as account supervisor. She will be working in the agency’s DTC/DTP division. Consulting POOL Ron Johnson The Lewin Group Appoints Executive VP Ron Johnson has been named executive VP of The Lewin Group, Falls Church, Va., the health and human services consulting firm that is part of the Quintiles family of companies. He oversees all operations at The Lewin Group. Mr. Johnson served as executive VP of Quintiles Consulting since 1997. Steven M. Niedelman FDA Official Joins Quintiles Consulting Steven M. Niedelman has been named executive VP, responsible for all operations at Quintiles Consulting, Vernon Hills, Ill., a unit of Quintiles Transnational that provides global regulatory, compliance, and validation consulting services. He spent 34 years at the U.S. Food and Drug Administration, most recently as deputy associate commissioner for regulatory operations. He has a bachelor’s degree in biology and chemistry from the College of Emporia. CRO POOL Peggy McHugh Registrat Names VP Registrat, a full-service, late-phase CRO based in Lexington, Ky., has appointed Peggy McHugh as VP of strategy and development. She provides strategic oversight and direction for clinical studies conducted by the company. She brings to Registrat more than 17 years of experience managing clinical-research projects. Pamela M. Spaniac Radiant Names President Pamela M. Spaniac has been named president of Radiant Research, a clinical research and development company based in Bellevue, Wash. She succeeds Michael K. Lester, who continues to serve as the company’s chairman and CEO. Ms. Spaniac previously served as Radiant’s senior VP and chief operating officer. She originally came to the company in 1998 from Res-Care. She is a certified public accountant with a B.A. from Scripps College. Dr. Jeffrey J. Stoddard Covance Names Risk Management Head Jeffrey J. Stoddard, M.D., has been named VP of medical and scientific affairs, risk-management, and postmarketing programs at Covance, a drug-development services company based in Princeton, N.J. Most recently, he was senior director of medical affairs at MedImmune. He earned a doctorate of medicine from the University of Wisconsin Medical School, completed a postdoctoral fellowship at the University of California, San Francisco, and did his residency at the Johns Hopkins Hospital, Department of Pediatrics. Media POOL Devin Gregorie Elsevier Builds Oncology Sales Team Elsevier Oncology has appointed Devin Gregorie as ad sales representative for The Journal of Supportive Oncology (JSO). Elsevier Oncology is a division of Elsevier, New York, an information-sharing company, creating advanced technologies to deliver research and clinical information to the desktop. Medical-Education POOL Meaghan Donovan Kaelynn Martindale CME Enterprise Builds Staff CME Enterprise announced today the addition of Meaghan Donovan as medical liaison to the continuing medical education (CME) team. CME Enterprise, Carmel, Ind., is the ACCME-accredited subsidiary of Deborah Wood Associates Healthcare Communications Group. Ms. Donovan researches, designs, and implements activities for healthcare professionals. She is currently completing her Ph.D. dissertation in pharmaceutical health services research, with a focus in pharmacoepidemiology. Ms. Donovan has an M.S. from the University of Maryland Baltimore School of Pharmacy and a bachelor’s degree in psychology from Providence College. Additionally, CME Enterprise has hired Kaelynn Martindale as managing director. In this role, she is responsible for managing the development and execution of the company’s strategic and tactical plans. Most recently, she was an instructor at Marian College. Ms. Martindale received an MBA from Indiana Wesleyan University, a B.S. in psychology from Purdue University, and an ASN from Indiana University’s School of Nursing. Marc Sirockman Anatstat Promotes Executive VP Marc Sirockman has been promoted to executive VP of Anatstat Health Education Media, Flemington, N.J. Anatstat produces health-education materials. Mr. Sirockman has more than 20 years of experience in sales, training, and sales management within the pharmaceutical and biotech industries. Service POOL Janet L. Brennan Dr. Harris Koffer RPS Expands Executive Team Janet L. Brennan has joined ReSearch Pharmaceutical Services as chief clinical officer and executive VP, global operations. RPS, Plymouth Meeting, Pa., is an employee-owned pharmaceutical resource organization that provides customized business process outsourcing solutions to the life-sciences industry. Additionally, Harris Koffer, Pharm.D. has been appointed president and chief operating office of RPS. Previously, Dr. Koffer was corporate executive VP and president, cardiac safety services, at Medifacts International. He earned both a B.S. in pharmacy and a doctor of pharmacy from the Philadelphia College of Pharmacy and Science. He completed a fellowship in clinical pharmacology at Thomas Jefferson University Hospital. Carlos Carrazana David Loeser Deborah Klein Walker Carlos Carrazana David Loeser Deborah Klein Walker Abt Names VPs Abt Associates, a research and consulting firm located in Cambridge, Mass., has promoted Carlos Carrazana to VP. Since joining Abt’s international health division in 2003, Mr. Carrazana has been responsible for the management and technical oversight of a portfolio of global and bilateral healthcare projects. Previously, he worked for Deloitte Touche Tohmatsu’s emerging markets division. He has an MPH in epidemiology from the University of Miami School of Medicine, an MBA in international finance from American University’s Kogod School of Business, and a B.S. in business economics from Bentley College. Additionally, Abt has promoted David Loeser to senior VP. Mr. Loeser previously was VP and chief financial officer. He joined Abt in 1996. He has a B.A. from the University of Rochester in economics and an MBA from the University of Southern California. Deborah Klein Walker also has been promoted to VP. She joined the company’s domestic health division in 2004. Previously, she spent 15 years with the Massachusetts Department of Public Health, most recently as associate commissioner, programs and prevention, and interim director of the Bureau of Substance Abuse Services. Dr. Walker graduated with high honors and great distinction from Mount Holyoke College. She earned both a master of education and a doctorate in human development at the Harvard University Graduate School of Education. Dr. Ninad Deshpanday AAIPharma Appoints VP of Business Development Ninad Deshpanday, Ph.D., has been named VP, pharmaceutical business development at AAIPharma, Wilmington, N.C., a global provider of product development and support services to the pharmaceutical, biotechnology, and medical-device industries. Dr. Deshpanday is responsible for all of the company’s North American business development activities in pharmaceutical development. Most recently, he was VP of drug product development for Synta Pharmaceuticals. Nancy E. Fagan MMS Adds Business Development Manager Nancy E. Fagan has joined Medical Marketing Service (MMS) as New Jersey-based business development manager. MMS, Wood Dale, Ill., provides lists and services for direct marketing to U.S. health professionals via broadcast e-mail, direct mail, broadcast fax, and telemarketing. Ms. Fagan has more than 15 years of medical list sales and direct marketing experience, most recently with SK&A. She has a B.S. in business administration, with a marketing minor, from St. Thomas Aquinas College. Don Marshall TVG Adds Chief Methodologist TVG Marketing Research and Consulting, Dresher, Pa., has named Don Marshall as VP and chief methodologist. TVG provides customized marketing research, strategic planning and consulting, and marketing training. Mr. Marshall heads the company’s advanced quantitative analysis team. He previously has held positions with a number of healthcare marketing research firms, most recently with Isis Research/Synovate Healthcare. David L. Schlotterbeck Cardinal Health Makes Key Appointment David L. Schlotterbeck has been appointed CEO of pharmaceutical and medical products at Cardinal Health. Cardinal Health, Dublin, Ohio, delivers integrated healthcare solutions. Mr. Schlotterbeck, 59, has assumed responsibility for the company’s pharmaceutical technologies and services (PTS) and medical products manufacturing (MPM) segments in addition to his previous responsibility for the clinical technologies and services (CTS) segment. Dr. Levi A. Sorrell MTI Adds Chief Statistician MTI Information Technologies, a provider of tailored, data-driven pharmaceutical marketing services, has hired Levi A. Sorrell as chief statistician, responsible for leading the company’s advanced analytics team. Dr. Sorrell comes to MTI, Langhorne, Pa., from NDCHealth/Wolters Kluwer Health Analytics, where he was account VP for advanced analytics. He earned his doctor of philosophy, M.S. in management, and bachelor of science degrees from the Massachusetts Institute of Technology. Technology POOL Karen Carroll Doug Fulling Mary Lenzen Dr. Frederick Wood Octagon Adds Key Staff Karen Carroll has been named senior director, project management, at Octagon Research Solutions, a Wayne, Pa.-based company offering regulatory, clinical, process, and IT solutions to the life-sciences industry. Ms. Carroll is responsible for project oversight activities for clinical data operations projects, client communication, project plans, forecasting, business development, and the daily operations of cross-functional teams. She was most recently the senior director for project management at MDS Pharma. Doug Fulling has joined Octagon as VP of business development. He directs and manages the company’s business development team and activities, spearheads initiatives to expand its business and client base, and drives the company’s domestic and international growth. Mr. Fulling previously was employed at MDS Pharma Services as head of North American sales for global clinical development services (Phase II-IV). Additionally, Octagon has hired Mary Lenzen and Dr. Frederick Wood as principal consultants in its Clinical Data Strategies division. Ms. Lenzen and Dr. Wood oversee Clinical Data Interchange Standards Consortium (CDISC) training initiatives and spearhead Octagon’s broader efforts in CDISC conversions, training, and thought leadership. Ms. Lenzen most recently was the leader of global clinical data standards at Pfizer. She has almost 30 years of pharmaceutical industry experience, and she has a master’s degree in computer science. Dr. Wood was most recently global data standards manager, clinical data and information management, at Procter & Gamble Pharmaceuticals. Bikash Chatterjee Calvin Wong Pharmatech Makes Key Leadership Changes Bikash Chatterjee has been appointed president of Pharmatech Associates, Foster City, Calif., a provider of technical and business solutions for the regulated life-sciences industry. Mr. Chatterjee previously served as the company’s chief operating officer. He holds a B.A. in biochemistry and a B.S. in chemical engineering from the University of California at San Diego. Pharmatech also has named Calvin Wong as chairman and CEO. Mr. Wong founded Pharmatech in 1995. He has a B.A. in microbiology from the University of California at Berkeley. Gregg Dearhammer i3 Statprobe Appoints President i3, an Ingenix company, has hired Gregg Dearhammer as president, i3 Statprobe, a clinical data services company based in Ann Arbor, Mich. Mr. Dearhammer comes to i3 from Kendle International, where he most recently was global VP of biometrics. Dr. Michael J. McKelvey eRT Names Chief Executive eResearchTechnology (eRT), a Philadelphia-based provider of centralized electrocardiographic (ECG) services and clinical-data technology and services, has appointed Michael J. McKelvey, Ph.D., as president and CEO. He succeeds Joseph Esposito. He comes to eRT from Parexel International, where he was corporate senior VP, clinical research services. Dr. McKelvey has Ph.D. and M.A. degrees from the Wharton School, University of Pennsylvania, and an A.B. degree from Williams College. Michael Pinto Model N Names Sales VP Model N, a provider of revenue-management solutions for the life-sciences industry, has appointed Michael Pinto to VP of sales. Mr. Pinto joins Model N, South San Francisco, Calif., from Octagon Solutions, where he was VP of sales. He has an MBA from New York University’s Leonard N. Stern School of Business and a bachelor’s degree in economics and computer science from Lafayette College. Please send your personnel announcements to email@example.com.